Design Therapeutics, Inc. (DSGN) Misses Q1 EPS by 2c

Design Therapeutics, Inc. (NASDAQ: DSGN) reported Q1 EPS of ($0.31), $0.02 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Design Therapeutics, Inc. (DSGN) click here.

You May Also Be Interested In

• The LGL Group (LGL) Misses Q2 EPS by 8c
• Bonk, Inc. posts $5.5M revenue in H1 2026, reports $7.88M net loss
• Chevron confirms oil and gas find in Angola's Block 0